Comparison 11. Cardiac surgery: adverse events.
Outcome or subgroup title | No. of studies | No. of participants | Statistical method | Effect size |
---|---|---|---|---|
1 VKAs versus platelet inhibitor | 1 | Risk Ratio (IV, Random, 95% CI) | Totals not selected | |
2 3‐month VKAs versus 3‐month platelet inhibitor | 1 | Risk Ratio (IV, Random, 95% CI) | Totals not selected |